BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2527097)

  • 1. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
    Hechtman P; Boulay B; Bayleran J; Andermann E
    Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients.
    Bayleran J; Hechtman P; Kolodny E; Kaback M
    Am J Hum Genet; 1987 Oct; 41(4):532-48. PubMed ID: 2959149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new form of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts.
    Hechtman P; Khoo K; Isaacs C
    Clin Genet; 1983 Sep; 24(3):206-15. PubMed ID: 6226462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A glycine250--> aspartate substitution in the alpha-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian family.
    Trop I; Kaplan F; Brown C; Mahuran D; Hechtman P
    Hum Mutat; 1992; 1(1):35-9. PubMed ID: 1301189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
    Bayleran J; Hechtman P; Saray W
    Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A.
    Navon R; Kopel R; Nutman J; Frisch A; Conzelmann E; Sandhoff K; Adam A
    Am J Hum Genet; 1985 Jan; 37(1):138-46. PubMed ID: 3156493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active arginine residues in beta-hexosaminidase. Identification through studies of the B1 variant of Tay-Sachs disease.
    Brown CA; Mahuran DJ
    J Biol Chem; 1991 Aug; 266(24):15855-62. PubMed ID: 1831451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A shortened beta-hexosaminidase alpha-chain in an Italian patient with infantile Tay-Sachs disease.
    Zokaeem G; Bayleran J; Kaplan P; Hechtman P; Neufeld EF
    Am J Hum Genet; 1987 Jun; 40(6):537-47. PubMed ID: 2954459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two abnormalities of hexosaminidase A in clinically normal individuals.
    Grebner EE; Mansfield DA; Raghavan SS; Kolodny EH; d'Azzo A; Neufeld EF; Jackson LG
    Am J Hum Genet; 1986 Apr; 38(4):505-14. PubMed ID: 2939713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tay-Sachs disease: B1 variant.
    Gordon BA; Gordon KE; Hinton GG; Cadera W; Feleki V; Bayleran J; Hechtman P
    Pediatr Neurol; 1988; 4(1):54-7. PubMed ID: 2976595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
    Harzer K
    Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
    Poulos A; Holding J; Carey WF
    Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic cause of a juvenile form of Tay-Sachs disease in a Lebanese child.
    Boustany RM; Tanaka A; Nishimoto J; Suzuki K
    Ann Neurol; 1991 Jan; 29(1):104-7. PubMed ID: 1996872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
    Inui K; Grebner EE; Jackson LG; Wenger DA
    Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
    Suzuki K; Vanier MT
    Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biochemical genetics of the hexosaminidase system in man.
    Beutler E
    Am J Hum Genet; 1979 Mar; 31(2):95-105. PubMed ID: 377957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-hexosaminidase in cultured normal and mutant human fibroblasts: an immunohistochemical and biochemical investigation.
    Elsafi ME; Elbashir MI; Hultberg B; Isaksson A; Hägerstrand I; Stenram U
    Scand J Clin Lab Invest; 1991 Dec; 51(8):711-4. PubMed ID: 1839650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease.
    Korneluk RG; Mahuran DJ; Neote K; Klavins MH; O'Dowd BF; Tropak M; Willard HF; Anderson MJ; Lowden JA; Gravel RA
    J Biol Chem; 1986 Jun; 261(18):8407-13. PubMed ID: 3013851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease.
    Akli S; Chelly J; Mezard C; Gandy S; Kahn A; Poenaru L
    J Biol Chem; 1990 May; 265(13):7324-30. PubMed ID: 2139660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemistry and genetics of Tay-Sachs disease.
    Gravel RA; Triggs-Raine BL; Mahuran DJ
    Can J Neurol Sci; 1991 Aug; 18(3 Suppl):419-23. PubMed ID: 1834320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.